Skip to main content
. 2016 Sep 30;56(5):505–514. doi: 10.1007/s40262-016-0452-x

Fig. 3.

Fig. 3

Predicted concentrations and weighted residuals for the necitumumab (a) base model and the (b) final model. Conc concentration